C.Uyemura & Co.,Ltd. (4966.T)
Osaka, JP
C.Uyemura & Co.,Ltd. is a global enterprise that manufactures and distributes a diverse range of products, including specialized plating chemicals, industrial chemicals, and non-ferrous metals, serving markets both within Japan and worldwide. Its business activities span four distinct segments: Surface Finishing Materials, Surface Finishing Machinery, Plating Job, and Real Estate Rental. Among its offerings are specialized plating equipment designed for printed wiring boards (PWBs) and aluminum magnetic disks, alongside comprehensive plating services for both plastics and PWBs. Furthermore, the company manages a real estate portfolio, encompassing the leasing of office spaces and residential apartment complexes. Established in 1848, C.Uyemura & Co.,Ltd. maintains its corporate headquarters in Osaka, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.50% | -1.54% | +2.12% | +15.72% | +64.21% | +60.53% | +158.82% | +280.52% | +521.84% | +865.47% | +2,454.59% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+9.5% ★ Q1'26: +25.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-1.0% Q1'26: -17.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+10.6% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+23.2% ★ Q1'26: +22.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+24.3% ★ Q1'26: +23.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.05× ★ Q1'26: 0.04× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 3 Rev. Ana. 3 EPS Ana. |
Mar 2027 3 Rev. Ana. 2 EPS Ana. |
Mar 2028 2 Rev. Ana. 2 EPS Ana. |
Mar 2029 1 Rev. Ana. |
Mar 2030 1 Rev. Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
46.25B
est: 48.40B (-4.4%)
|
47.57B
est: 47.00B (+1.2%)
|
42.08B
est: 44.00B (-4.4%)
|
48.12B
est: 47.05B (+2.3%)
|
51.98B
est: 51.50B (+0.9%)
|
52.22B
est: 49.80B (+4.9%)
|
55.95B
est: 53.50B (+4.6%)
|
72.30B
est: 69.30B (+4.3%)
|
85.75B
est: 84.80B (+1.1%)
|
80.26B
est: 78.00B (+2.9%)
|
83.85B
est: 84.24B (-0.5%)
|
89.28B
87.48B – 90.36B
+6.0% YoY
|
93.83B
90.60B – 95.86B
+5.1% YoY
|
101.69B
100.08B – 103.30B
+8.4% YoY
|
118.90B
115.96B – 121.12B
+16.9% YoY
|
138.03B
134.61B – 140.60B
+16.1% YoY
|
153.24B
149.45B – 156.10B
+11.0% YoY
|
| EBITDA |
8.27B
est: 10.94B (-24.4%)
|
8.79B
est: 10.62B (-17.3%)
|
7.63B
est: 9.94B (-23.3%)
|
10.37B
est: 10.63B (-2.4%)
|
10.26B
est: 11.64B (-11.8%)
|
9.68B
est: 11.25B (-14.0%)
|
11.56B
est: 12.09B (-4.4%)
|
15.86B
est: 15.66B (+1.3%)
|
17.07B
est: 19.16B (-10.9%)
|
16.99B
est: 22.66B (-25.0%)
|
21.09B
est: 26.93B (-21.7%)
|
28.54B
27.97B – 28.89B
+6.0% YoY
|
30.00B
28.96B – 30.65B
+5.1% YoY
|
32.51B
31.99B – 33.03B
+8.4% YoY
|
38.01B
37.07B – 38.72B
+16.9% YoY
|
44.13B
43.04B – 44.95B
+16.1% YoY
|
48.99B
47.78B – 49.90B
+11.0% YoY
|
| EBIT |
6.46B
est: 9.59B (-32.7%)
|
6.70B
est: 9.32B (-28.1%)
|
5.67B
est: 8.72B (-35.0%)
|
8.32B
est: 9.33B (-10.8%)
|
8.21B
est: 10.21B (-19.6%)
|
7.54B
est: 9.87B (-23.6%)
|
9.49B
est: 10.61B (-10.5%)
|
13.95B
est: 13.74B (+1.5%)
|
15.05B
est: 16.81B (-10.5%)
|
14.99B
est: 21.31B (-29.6%)
|
18.83B
est: 24.60B (-23.5%)
|
26.07B
25.54B – 26.39B
+6.0% YoY
|
27.40B
26.46B – 27.99B
+5.1% YoY
|
29.69B
29.22B – 30.16B
+8.4% YoY
|
34.72B
33.86B – 35.37B
+16.9% YoY
|
40.31B
39.31B – 41.06B
+16.1% YoY
|
44.75B
43.64B – 45.58B
+11.0% YoY
|
| Net Income |
3.79B
est: 3.74B (+1.3%)
|
4.25B
est: 4.36B (-2.5%)
|
5.29B
est: 3.60B (+46.8%)
|
5.34B
est: 4.82B (+10.6%)
|
5.65B
est: 4.87B (+16.0%)
|
5.36B
est: 4.77B (+12.3%)
|
7.13B
est: 5.20B (+37.1%)
|
9.68B
est: 9.30B (+4.1%)
|
10.55B
est: 11.08B (-4.8%)
|
10.92B
est: 9.79B (+11.6%)
|
14.08B
est: 13.85B (+1.7%)
|
14.66B
14.09B – 15.24B
+5.9% YoY
|
16.09B
15.59B – 16.59B
+9.7% YoY
|
17.93B
17.76B – 18.63B
+11.4% YoY
|
—
— – —
-100.0% YoY
|
—
— – —
|
—
— – —
|
| SGA |
3.50B
est: 5.54B (-36.8%)
|
7.17B
est: 5.38B (+33.3%)
|
6.94B
est: 5.03B (+37.8%)
|
7.26B
est: 5.38B (+34.8%)
|
7.37B
est: 5.89B (+25.1%)
|
7.08B
est: 5.70B (+24.3%)
|
6.86B
est: 6.12B (+12.1%)
|
7.67B
est: 7.93B (-3.2%)
|
8.90B
est: 9.70B (-8.3%)
|
9.41B
est: 8.92B (+5.4%)
|
10.25B
est: 9.58B (+7.1%)
|
10.15B
9.95B – 10.27B
+6.0% YoY
|
10.67B
10.30B – 10.90B
+5.1% YoY
|
11.56B
11.38B – 11.75B
+8.4% YoY
|
13.52B
13.18B – 13.77B
+16.9% YoY
|
15.69B
15.31B – 15.99B
+16.1% YoY
|
17.42B
16.99B – 17.75B
+11.0% YoY
|
| EPS |
208.14
est: 232.00 (-10.3%)
|
233.45
est: 270.20 (-13.6%)
|
292.41
est: 223.50 (+30.8%)
|
296.41
est: 299.10 (-0.9%)
|
314.00
est: 302.15 (+3.9%)
|
299.30
est: 295.90 (+1.1%)
|
402.89
est: 322.40 (+25.0%)
|
559.61
est: 576.50 (-2.9%)
|
636.84
est: 688.33 (-7.5%)
|
673.41
est: 610.90 (+10.2%)
|
872.87
est: 867.80 (+0.6%)
|
905.53
873.16 – 944.87
+4.3% YoY
|
997.50
966.36 – 1,028.64
+10.2% YoY
|
1,127.70
1,100.65 – 1,154.75
+13.1% YoY
|
—
— – —
-100.0% YoY
|
—
— – —
|
—
— – —
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | NYLI International Small-Mid Cap Equity ETF NISM | 0.63% | 156.7K | 0.70% |
| 2 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.26% | 998.6K | 0.58% |
| 3 | iShares MSCI Japan Small-Cap ETF SCJ | 0.14% | 368.6K | 0.50% |
| 4 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.10% | 580.9K | 0.58% |
| 5 | WisdomTree International SmallCap Dividend Fund DLS | 0.09% | 938.4K | 0.58% |
| 6 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.09% | 385.0K | 0.48% |
| 7 | WisdomTree Japan Hedged Equity Fund DXJ | 0.06% | 4.52M | 0.48% |
| 8 | WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc DXJF.MI | 0.06% | 562.8K | 0.45% |
| 9 | WisdomTree Japan Equity UCITS ETF - USD Hedged Acc DXJA.L | 0.06% | 494.0K | 0.48% |
| 10 | WisdomTree Japan Equity UCITS ETF DXJ.L | 0.06% | 494.0K | 0.48% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hiroya Uemura | President & Representative Director | 379M | male |
| Katsuhisa Tanabe | Director of Central Research Lab., First Dev. Dep. & Central Research Lab and Director | — | male |
| Maiko Uyemura | Assistant to the President & Director | — | female |
| Tsutomu Sekiya | Deputy GM of Sales HQ, Tokyo Branch & Tokyo Sales Department and Director | — | male |
| Tsuyoshi Yoneda | Accounting & Finance Department Manager | — | — |
| Yasushi Shimada | MD, Director of Manufacturing Division, Hirakata Factory Manager & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4966.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
